|
JPS59186924A
(ja)
|
1983-04-08 |
1984-10-23 |
Kureha Chem Ind Co Ltd |
ヒト免疫グロブリン結合抗腫瘍剤
|
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
|
US5395855A
(en)
|
1990-05-07 |
1995-03-07 |
Ciba-Geigy Corporation |
Hydrazones
|
|
US5484612A
(en)
|
1993-09-22 |
1996-01-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
|
|
US6011069A
(en)
|
1995-12-26 |
2000-01-04 |
Nisshin Flour Milling Co., Ltd. |
Multidrug resistance inhibitors
|
|
US20020077461A1
(en)
|
1996-04-24 |
2002-06-20 |
Soren Bjorn |
Pharmaceutical formulation
|
|
US6692742B1
(en)
|
1996-06-27 |
2004-02-17 |
Chugai Seiyaku Kabushiki Kaisha |
Remedies for myeloma to be used together with nitrogen mustard antitumor agents
|
|
US6121245A
(en)
|
1997-01-29 |
2000-09-19 |
Firshein; Richard N. |
Method of treating cancer using alkylglycerols in conjunction with chemotherapy
|
|
CO4950519A1
(es)
|
1997-02-13 |
2000-09-01 |
Novartis Ag |
Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
|
|
US20040072889A1
(en)
|
1997-04-21 |
2004-04-15 |
Pharmacia Corporation |
Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
|
|
WO1999001118A2
(en)
|
1997-07-01 |
1999-01-14 |
Atherogenics, Inc. |
Antioxidant enhancement of therapy for hyperproliferative conditions
|
|
GB9721069D0
(en)
|
1997-10-03 |
1997-12-03 |
Pharmacia & Upjohn Spa |
Polymeric derivatives of camptothecin
|
|
US6100254A
(en)
|
1997-10-10 |
2000-08-08 |
Board Of Regents, The University Of Texas System |
Inhibitors of protein tyrosine kinases
|
|
US6288234B1
(en)
|
1998-06-08 |
2001-09-11 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
|
WO2000002555A1
(en)
|
1998-07-09 |
2000-01-20 |
Nardella Francis A |
Methods and compositions for the treatment of chronic lymphocytic leukemia
|
|
PT1107964E
(pt)
|
1998-08-11 |
2010-06-11 |
Novartis Ag |
Derivados de isoquinolina com actividade inibidora da angiogénese
|
|
US6326390B1
(en)
|
1998-08-25 |
2001-12-04 |
King Pharmaceuticals Reseach And Development, Inc. |
Use of adenosine A3 receptor antagonists to inhibit tumor growth
|
|
CN1660840A
(zh)
|
1999-03-30 |
2005-08-31 |
诺瓦提斯公司 |
治疗炎性疾病的酞嗪衍生物
|
|
WO2008109417A1
(en)
|
2007-03-02 |
2008-09-12 |
Case Western Reserve University |
Mgmt inhibitor combinations for the treatment of neoplastic disorders
|
|
US7811981B2
(en)
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
|
AR030557A1
(es)
|
2000-04-14 |
2003-08-27 |
Jagotec Ag |
Una tableta en multicapa de liberacion controlada y metodo de tratamiento
|
|
US6921722B2
(en)
|
2000-05-30 |
2005-07-26 |
Ebara Corporation |
Coating, modification and etching of substrate surface with particle beam irradiation of the same
|
|
US20030072794A1
(en)
|
2000-06-09 |
2003-04-17 |
Teni Boulikas |
Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
|
|
US6613736B2
(en)
|
2000-06-16 |
2003-09-02 |
Thomas T. Aoki |
System and method for treating eye and nerve diseases in diabetic and non-diabetic patients
|
|
CN100548375C
(zh)
|
2000-06-23 |
2009-10-14 |
田边三菱制药株式会社 |
抗肿瘤作用增效剂
|
|
WO2002022605A1
(en)
|
2000-09-15 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6660731B2
(en)
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6610677B2
(en)
|
2000-09-15 |
2003-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US7473691B2
(en)
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
CN1116875C
(zh)
|
2000-10-19 |
2003-08-06 |
南京振中生物工程有限公司 |
紫杉醇脂质组合物及其制备方法
|
|
US6503914B1
(en)
|
2000-10-23 |
2003-01-07 |
Board Of Regents, The University Of Texas System |
Thienopyrimidine-based inhibitors of the Src family
|
|
AU2738302A
(en)
|
2000-10-30 |
2002-05-15 |
Euro Celtique Sa |
Controlled release hydrocodone formulations
|
|
US7619005B2
(en)
|
2000-11-01 |
2009-11-17 |
Cognition Pharmaceuticals Llc |
Methods for treating cognitive impairment in humans with Multiple Sclerosis
|
|
US20020155565A1
(en)
|
2000-11-10 |
2002-10-24 |
Pilar Garin-Chesa |
FAP-activated anti-tumor compounds
|
|
US6989385B2
(en)
|
2000-12-21 |
2006-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US20100098691A1
(en)
|
2001-01-24 |
2010-04-22 |
S'bio Pte Ltd |
Combination of benzimidazole anti-cancer agent and a second anti-cancer agent
|
|
JP4460892B2
(ja)
|
2001-06-21 |
2010-05-12 |
ジェネンテック インコーポレイテッド |
徐放性組成物
|
|
US7005445B2
(en)
|
2001-10-22 |
2006-02-28 |
The Research Foundation Of State University Of New York |
Protein kinase and phosphatase inhibitors and methods for designing them
|
|
US20030158118A1
(en)
|
2001-11-26 |
2003-08-21 |
Weidner Morten Sloth |
Combination of cimetidine and cysteine derivatives for treating cancer
|
|
UA76810C2
(uk)
|
2001-12-10 |
2006-09-15 |
Мерк Енд Ко., Інк. |
Фармацевтична композиція антагоніста рецептора тахікініну у формі наночастинок
|
|
US7045534B2
(en)
|
2002-02-12 |
2006-05-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of reducing angiogenesis
|
|
WO2003070823A2
(en)
|
2002-02-20 |
2003-08-28 |
The General Hospital Corporation |
Conjugates comprising a biodegradable polymer and uses therefor
|
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
AU2003286711A1
(en)
|
2002-10-25 |
2004-05-13 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
|
TW200413381A
(en)
|
2002-11-04 |
2004-08-01 |
Hoffmann La Roche |
Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
|
|
US7112676B2
(en)
|
2002-11-04 |
2006-09-26 |
Hoffmann-La Roche Inc. |
Pyrimido compounds having antiproliferative activity
|
|
AU2003295600A1
(en)
|
2002-11-14 |
2004-06-15 |
Dharmacon, Inc. |
Functional and hyperfunctional sirna
|
|
US7276519B2
(en)
|
2002-11-25 |
2007-10-02 |
Wyeth |
Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
|
|
CL2003002287A1
(es)
|
2002-11-25 |
2005-01-14 |
Wyeth Corp |
COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
|
|
BR0317885A
(pt)
|
2002-12-30 |
2005-12-06 |
Celgene Corp |
Composto, isÈmeros s e r enantiomericamente puros do mesmo, composição farmacêutica e métodos de inibir pde4 e mmp, de modular a produção de tnf-alfa, de tratar ou prevenir mds, de tratar doença mieloproliferativa, angiogênese indesejada, câncer, uma doença, inflamação dos pulmões, depressão, distúrbio pulmonar obstrutivo crÈnico, doença inflamatória do intestino, dermatite atópica, psorìase, doença de crohn, artrite reumatóide, asma, eslcerose múltipla e doença cardìaca em um mamìfero e de tratar, prevenir ou controlar a sìndrome de dor regional complexa
|
|
DK1603570T5
(da)
|
2003-02-26 |
2013-12-09 |
Sugen Inc |
Aminoheteroarylforbindelser som proteinkinaseinhibitorer
|
|
NZ567952A
(en)
|
2003-03-24 |
2009-12-24 |
Sequoia Pharmaceuticals Inc |
Long acting biologically active conjugates
|
|
TW200502236A
(en)
|
2003-03-28 |
2005-01-16 |
Hoffmann La Roche |
Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
|
|
US7220706B1
(en)
|
2003-05-14 |
2007-05-22 |
Praxair S.T. Technology, Inc. |
Enhanced melt-textured growth
|
|
US7385055B2
(en)
|
2003-05-19 |
2008-06-10 |
Board Of Trustees Of Michigan State University |
Preparation of hymenialdisine derivatives and use thereof
|
|
US7842835B2
(en)
|
2003-07-07 |
2010-11-30 |
Georgetown University |
Histone deacetylase inhibitors and methods of use thereof
|
|
US20050009891A1
(en)
|
2003-07-09 |
2005-01-13 |
Lee Francis Y. |
Combination of SRC Kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
|
|
WO2005013982A1
(en)
|
2003-08-06 |
2005-02-17 |
Vertex Pharmaceuticals Incorporated |
Aminotriazole compounds useful as inhibitors of protein kinases
|
|
EP1660477B1
(en)
|
2003-08-07 |
2008-12-10 |
Schering Corporation |
Novel farnesyl protein transferase inhibitors as antitumor agents
|
|
TW200524940A
(en)
|
2003-10-02 |
2005-08-01 |
Salmedix Inc |
Indole derivatives
|
|
HUP0303313A2
(hu)
|
2003-10-09 |
2005-07-28 |
Richter Gedeon Vegyészeti Gyár Rt. |
Transzdermális gyógyszerkészítmények
|
|
US7169781B2
(en)
|
2003-10-17 |
2007-01-30 |
Hoffmann-La Roche Inc. |
Imidazole derivatives and their use as pharmaceutical agents
|
|
SG146681A1
(en)
|
2003-11-06 |
2008-10-30 |
Wyeth Corp |
4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml)
|
|
US7491725B2
(en)
|
2004-02-06 |
2009-02-17 |
Bristol-Myers Squibb Company |
Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
|
|
EP1719771A1
(en)
|
2004-02-19 |
2006-11-08 |
Takeda Pharmaceutical Company Limited |
Pyrazoloquinolone derivative and use thereof
|
|
KR100881050B1
(ko)
|
2004-03-15 |
2009-01-30 |
에프. 호프만-라 로슈 아게 |
신규 디클로로―페닐―피리도 [2,3-ｄ] 피리미딘 유도체, 그들의 제조 및 약제로서의 용도
|
|
US7910621B2
(en)
|
2004-03-22 |
2011-03-22 |
The Regents Of The University Of Michigan |
Small molecule antagonists of XIAP family proteins
|
|
CN101010298A
(zh)
|
2004-04-05 |
2007-08-01 |
默克Hdac研究有限责任公司 |
组蛋白脱乙酰酶抑制剂前药
|
|
TW200538149A
(en)
|
2004-05-20 |
2005-12-01 |
Telik Inc |
Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound
|
|
TW200600091A
(en)
|
2004-05-21 |
2006-01-01 |
Telik Inc |
Sulfonylethyl phosphorodiamidates
|
|
SI1771474T1
(sl)
|
2004-07-20 |
2010-06-30 |
Genentech Inc |
Inhibitorji angiopoetinu podobnega proteina kombinacije in njihova uporaba
|
|
SE0402025D0
(sv)
|
2004-08-13 |
2004-08-13 |
Active Biotech Ab |
Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
|
|
US7479561B2
(en)
|
2004-08-16 |
2009-01-20 |
Wyeth |
4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors
|
|
AU2005279337A1
(en)
|
2004-08-31 |
2006-03-09 |
F. Hoffmann-La Roche Ag |
Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
|
|
US20060100226A1
(en)
|
2004-09-10 |
2006-05-11 |
Sikorski James A |
2-Thiopyrimidinones as therapeutic agents
|
|
CA2579406A1
(en)
|
2004-09-21 |
2006-03-30 |
F.Hoffmann-La Roche Ag |
6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as protein kinase inhibitors
|
|
US7355677B2
(en)
|
2004-12-09 |
2008-04-08 |
Asml Netherlands B.V. |
System and method for an improved illumination system in a lithographic apparatus
|
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
|
JP2008525355A
(ja)
|
2004-12-23 |
2008-07-17 |
エフ．ホフマン−ラ ロシュ アーゲー |
ベンズアミド誘導体、これらの製造及び医薬剤としての使用。
|
|
CN101830899A
(zh)
|
2004-12-23 |
2010-09-15 |
霍夫曼-拉罗奇有限公司 |
杂环氨基甲酸酯衍生物,它们的制备及作为药剂的应用
|
|
US7968574B2
(en)
|
2004-12-28 |
2011-06-28 |
Kinex Pharmaceuticals, Llc |
Biaryl compositions and methods for modulating a kinase cascade
|
|
MX2007009888A
(es)
|
2005-02-17 |
2007-10-16 |
Synta Pharmaceuticals Corp |
Compuestos para el tratamiento de trastornos proliferativos.
|
|
US20060229277A1
(en)
|
2005-04-08 |
2006-10-12 |
Orbus Pharma, Inc. |
Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor
|
|
US8242103B2
(en)
|
2005-05-19 |
2012-08-14 |
Merck Sharp & Dohme Limited |
Sulphamides for treatment of cancer
|
|
EA016838B1
(ru)
|
2005-06-07 |
2012-07-30 |
Йельский Университет |
Способы лечения рака и других заболеваний или патологических состояний с применением клевудина (lfmau) и телбивудина (ldt)
|
|
MX2007016248A
(es)
|
2005-06-15 |
2008-03-07 |
Cardiome Pharma Corp |
Procedimiento sintetico para la preparacion de compuestos de eter aminociclohexilico.
|
|
WO2007002254A2
(en)
|
2005-06-23 |
2007-01-04 |
Merck & Co., Inc. |
Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
|
|
DK3248613T3
(da)
|
2005-07-18 |
2022-03-14 |
Seagen Inc |
Beta-glucuronid-lægemiddel-linkerkonjugater
|
|
EP1912987A1
(en)
|
2005-08-01 |
2008-04-23 |
F. Hoffmann-Roche AG |
Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents
|
|
JP2009507843A
(ja)
|
2005-09-09 |
2009-02-26 |
シェーリング コーポレイション |
アザ縮合サイクリン依存性キナーゼ阻害剤
|
|
BRPI0617663A2
(pt)
|
2005-10-21 |
2011-08-02 |
Panacea Biotec Ltd |
composições aperfeiçoadas para terapia de cáncer
|
|
JP5191391B2
(ja)
|
2005-11-01 |
2013-05-08 |
ターゲジェン インコーポレーティッド |
キナーゼのビ−アリールメタ−ピリミジン阻害剤
|
|
MX2008005814A
(es)
|
2005-11-03 |
2008-10-15 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de cinasa.
|
|
ATE438381T1
(de)
|
2005-11-18 |
2009-08-15 |
Synhton B V |
Zolpidemtabletten
|
|
SG10202003901UA
(en)
|
2005-12-13 |
2020-05-28 |
Incyte Holdings Corp |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
|
|
US8014957B2
(en)
*
|
2005-12-15 |
2011-09-06 |
Fred Hutchinson Cancer Research Center |
Genes associated with progression and response in chronic myeloid leukemia and uses thereof
|
|
WO2007081751A2
(en)
|
2006-01-05 |
2007-07-19 |
The Johns Hopkins University |
Compositions and methods for the treatment of cancer
|
|
ES2329419T3
(es)
|
2006-01-31 |
2009-11-25 |
F. Hoffmann-La Roche Ag |
7h-pirido(3,4-d)pirimidin-8-onas, su preparacion y uso como inhibidores de proteinas cinasas.
|
|
JP5220724B2
(ja)
|
2006-03-14 |
2013-06-26 |
ニューレン ファーマシューティカルズ リミテッド |
グリシル−２−メチルプロリルグルタミン酸塩の経口製剤
|
|
MX2008012404A
(es)
|
2006-03-28 |
2008-10-09 |
Novartis Ag |
Derivados de amida y su aplicacion para el tratamiento de enfermedades relacionadas con proteina-g.
|
|
US20090098137A1
(en)
|
2006-04-05 |
2009-04-16 |
Novartis Ag |
Combinations of therapeutic agents for treating cancer
|
|
CA2649861A1
(en)
|
2006-04-26 |
2007-11-08 |
Merck & Co., Inc. |
Disubstituted aniline compounds
|
|
US8299052B2
(en)
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
|
GB0609378D0
(en)
|
2006-05-11 |
2006-06-21 |
Novartis Ag |
Organic compounds
|
|
US7964728B2
(en)
|
2006-07-06 |
2011-06-21 |
Solvay Pharmaceuticals B.V. |
Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition
|
|
TW200813021A
(en)
|
2006-07-10 |
2008-03-16 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
|
AU2007276405A1
(en)
|
2006-07-17 |
2008-01-24 |
Novartis Ag |
Sulphonylaminocarbonyl derivatives of bile acid amides for use as immunomodulators
|
|
US8080252B2
(en)
|
2006-07-19 |
2011-12-20 |
The Cleveland Clinic Foundation |
Compounds and methods of modulating angiogenesis
|
|
MX2009000824A
(es)
|
2006-07-24 |
2009-02-04 |
Tetralogic Pharmaceuticals Cor |
Antagonistas dimericos de las proteinas inhibidoras de la apoptosis.
|
|
NZ574979A
(en)
|
2006-08-07 |
2012-06-29 |
Abbott Biotherapeutics Corp |
Compositions and methods using anti-cs1 antibodies to treat multiple myeloma
|
|
EP2057164A1
(en)
|
2006-08-07 |
2009-05-13 |
Incyte Corporation |
Triazolotriazines as kinase inhibitors
|
|
AU2007284537B2
(en)
|
2006-08-17 |
2012-04-12 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate HSP90 activity
|
|
US8119617B2
(en)
|
2006-08-23 |
2012-02-21 |
Novartis Ag |
aSMase inhibitors
|
|
US8222288B2
(en)
|
2006-08-30 |
2012-07-17 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of MDM2 and the uses thereof
|
|
BRPI0719123A2
(pt)
|
2006-09-01 |
2013-12-17 |
Cylene Pharmaceuticals Inc |
Moduladores de serina-treonina proteína cinase e parp
|
|
WO2008030883A2
(en)
|
2006-09-05 |
2008-03-13 |
Bipar Sciences, Inc. |
Treatment of cancer
|
|
US8084471B2
(en)
|
2006-09-05 |
2011-12-27 |
Yale University |
Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides
|
|
US8242080B2
(en)
|
2006-10-13 |
2012-08-14 |
The Regents Of The University Of California |
Inhibitors of the EGFR kinase targeting the asymmetric activating dimer interface
|
|
JP5103604B2
(ja)
|
2006-10-31 |
2012-12-19 |
メルク・シャープ・アンド・ドーム・コーポレーション |
プロテインキナーゼ阻害剤としての２−アミノチアゾール−４−カルボン酸アミド
|
|
WO2008054792A2
(en)
|
2006-10-31 |
2008-05-08 |
University Of Toledo |
Na+/k+-atpase-specific peptide inhibitors/activators of src and src family kinases
|
|
WO2008058126A2
(en)
|
2006-11-06 |
2008-05-15 |
Supergen, Inc. |
Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
|
|
US20120164075A1
(en)
|
2006-11-21 |
2012-06-28 |
Jina Pharmaceuticals, Inc. |
Endoxifen methods and compositions in the treatment of mammalian diseases
|
|
US20080125397A1
(en)
|
2006-11-28 |
2008-05-29 |
Telik, Inc. |
2 (SULFONYL)ETHYL N,N,N',N' tetrakis(2 chloroethyl)phosphorodia
|
|
US7655799B2
(en)
|
2006-11-29 |
2010-02-02 |
Telik, Inc. |
2{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidates
|
|
WO2008073918A1
(en)
|
2006-12-11 |
2008-06-19 |
Kempharm, Inc. |
Non-standard amino acid conjugates of amphetamine and processes for making and using the same
|
|
EP1932820A1
(en)
|
2006-12-14 |
2008-06-18 |
Bp Oil International Limited |
Process for manufacturing neohexene
|
|
US8834920B2
(en)
|
2006-12-21 |
2014-09-16 |
Alza Corporation |
Liposome composition for targeting egfr receptor
|
|
WO2008079973A2
(en)
|
2006-12-21 |
2008-07-03 |
Centocor, Inc. |
Egfr binding peptides and uses thereof
|
|
US7956216B2
(en)
*
|
2006-12-21 |
2011-06-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Alpha-helical mimetics
|
|
US20080293648A1
(en)
|
2007-01-05 |
2008-11-27 |
Saha Pharmaceuticals, Inc. |
Compositions and Methods for Cancer Treatment
|
|
WO2008095908A1
(en)
|
2007-02-06 |
2008-08-14 |
Novartis Ag |
1-benzenesulfonyl-1h-indole derivatives as inhibitors of ccr9 activity
|
|
US20100069458A1
(en)
|
2007-02-15 |
2010-03-18 |
Peter Wisdom Atadja |
Combination of lbh589 with other therapeutic agents for treating cancer
|
|
KR101164718B1
(ko)
|
2007-03-09 |
2012-07-11 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
신규 화합물 및 이의 표적에 관한 조성물 및 방법
|
|
WO2008112277A2
(en)
|
2007-03-13 |
2008-09-18 |
Wake Forest University |
Compositions and methods for treating cancer
|
|
MY150697A
(en)
|
2007-04-10 |
2014-02-28 |
Exelixis Inc |
Methods of treating cancer using pyridopyrimdinone inhibitors of p13k alpha
|
|
CA2681311A1
(en)
|
2007-04-13 |
2008-10-23 |
Novartis Ag |
Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
|
|
TWI448284B
(zh)
|
2007-04-24 |
2014-08-11 |
Theravance Inc |
雙效抗高血壓劑
|
|
US7838495B2
(en)
|
2007-04-27 |
2010-11-23 |
University Of Maryland, Baltimore |
Compositions and methods of use of EPB1, and ErbB3 binding protein
|
|
JP5389785B2
(ja)
|
2007-05-02 |
2014-01-15 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼ阻害剤として有用なチアゾールおよびピラゾール
|
|
US20110021440A1
(en)
|
2007-05-16 |
2011-01-27 |
University Of Maryland, Baltimore |
Apoptotic pathway targeting for the diagnosis and treatment of cancer
|
|
US8367078B2
(en)
|
2007-06-06 |
2013-02-05 |
University Of Florida Research Foundation, Inc. |
Kinase inhibitor compounds
|
|
US20110288023A1
(en)
|
2007-06-08 |
2011-11-24 |
The Regents Of The University Of California Office Of Technology Transfer |
Cancer drug delivery using modified transferrin
|
|
WO2009003911A1
(en)
|
2007-06-29 |
2009-01-08 |
4Sc Ag |
Thiophene-imidazopyridines
|
|
US20090274698A1
(en)
|
2007-07-06 |
2009-11-05 |
Shripad Bhagwat |
Combination anti-cancer therapy
|
|
EP2545938A1
(en)
|
2007-08-03 |
2013-01-16 |
Abbott Biotherapeutics Corp. |
Therapeutic use of anti-tweak receptor antibodies
|
|
HRP20160625T1
(hr)
|
2007-09-10 |
2016-08-12 |
Boston Biomedical, Inc. |
Novi inhibitori stat3 signalnog puta i inhibitori matičnih stanica raka
|
|
WO2009045504A1
(en)
|
2007-10-04 |
2009-04-09 |
President And Fellows Of Harvard College |
Methods and compositions for treating cancer and modulating signal transduction and metabolism pathways
|
|
DK2211904T3
(en)
|
2007-10-19 |
2016-10-24 |
Seattle Genetics Inc |
Cd19-binding agents and uses thereof
|
|
EP2211620B1
(en)
|
2007-10-25 |
2013-12-25 |
Merck Sharp & Dohme Corp. |
3-PYRAZIN SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AS JANUS KINASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES
|
|
EP2215094B1
(en)
|
2007-11-15 |
2016-01-27 |
YM BioSciences Australia Pty Ltd |
N-containing heterocyclic compounds
|
|
EP2220073B1
(en)
|
2007-11-15 |
2014-09-03 |
MSD Italia S.r.l. |
Pyridazinone derivatives as parp inhibitors
|
|
UA104849C2
(uk)
|
2007-11-16 |
2014-03-25 |
Інсайт Корпорейшн |
4-піразоліл-n-арилпіримідин-2-аміни і 4-піразоліл-n-гетероарилпіримідин-2-аміни як інгібітори кіназ janus
|
|
CN101444490A
(zh)
*
|
2007-11-26 |
2009-06-03 |
天津市金圭谷木糖醇有限公司 |
一种含脱水卫矛醇经注射给药的制剂及其制备方法
|
|
CN101450100A
(zh)
*
|
2007-11-28 |
2009-06-10 |
天津金世制药有限公司 |
一种治疗急慢性粒细胞白血病的药物组合物
|
|
WO2009076629A2
(en)
|
2007-12-12 |
2009-06-18 |
The Regents Of The University Of Michigan |
Compositions and methods for treating cancer
|
|
PT2240172E
(pt)
|
2007-12-21 |
2014-05-28 |
Novartis Ag |
Combinação de nilotinib e clorambucilo para o tratamento da leucemia linfocítica crónica
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
DE112009000300T5
(de)
|
2008-02-08 |
2011-01-20 |
Aileron Therapeutics, Inc., Cambridge |
Therapeutische Peptidomimetische Makrocyclen
|
|
WO2009102707A2
(en)
|
2008-02-11 |
2009-08-20 |
Auspex Pharmaceuticals, Inc. |
Substituted oxazaphosphorines
|
|
US20090209340A1
(en)
|
2008-02-14 |
2009-08-20 |
Aruze Gaming America, Inc. |
Gaming Apparatus Capable of Conversation with Player and Control Method Thereof
|
|
US20110046071A1
(en)
|
2008-03-05 |
2011-02-24 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
GLP-1 Receptor Agonists And Related Active Pharmaceutical Ingredients For Treatment Of Cancer
|
|
HUE029767T2
(en)
|
2008-03-11 |
2017-04-28 |
Incyte Holdings Corp |
JAK inhibitor azetidine and cyclobutane derivatives
|
|
EP2110377A1
(en)
|
2008-04-15 |
2009-10-21 |
DAC S.r.l. |
Spirocyclic derivatives as histone deacetylase inhibitors
|
|
NZ610239A
(en)
|
2008-04-30 |
2014-11-28 |
Immunogen Inc |
Cross-linkers and their uses
|
|
WO2009143018A2
(en)
|
2008-05-19 |
2009-11-26 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
JP2011522048A
(ja)
|
2008-06-03 |
2011-07-28 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Ａｋｔ活性の阻害剤
|
|
GB2475183B
(en)
|
2008-06-04 |
2011-11-23 |
Gw Pharma Ltd |
Cannabinoids in combination with non-cannabinoid chemotherapeutic agent that are selective estrogen receptor modulators
|
|
EP2133334A1
(en)
|
2008-06-09 |
2009-12-16 |
DAC S.r.l. |
Heterocyclic derivatives as HDAC inhibitors
|
|
BRPI0914790A2
(pt)
*
|
2008-06-17 |
2015-10-20 |
Wyeth Llc |
uso de um composto de vinorelbina e um composto de hki-272, composição farmacêutica e produto e kit para o tratamento de neoplasma
|
|
US8207195B2
(en)
|
2008-06-26 |
2012-06-26 |
Inspire Pharmaceuticals, Inc. |
Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds
|
|
JP5465720B2
(ja)
|
2008-07-08 |
2014-04-09 |
インサイト・コーポレイション |
インドールアミン２，３−ジオキシゲナーゼの阻害剤としての１，２，５−オキサジアゾール
|
|
WO2010009334A1
(en)
|
2008-07-17 |
2010-01-21 |
Colorado State University Research Foundation |
Method for preparing largazole analogs and uses thereof
|
|
JO3041B1
(ar)
|
2008-07-25 |
2016-09-05 |
Galapagos Nv |
مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
|
|
US20120230991A1
(en)
|
2008-07-29 |
2012-09-13 |
Douglas Kim Graham |
Methods and compounds for enhancing anti-cancer therapy
|
|
WO2010021822A2
(en)
|
2008-07-30 |
2010-02-25 |
The Regents Of The University Of California |
Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites
|
|
WO2010014913A1
(en)
|
2008-08-01 |
2010-02-04 |
Ventirx Pharmaceuticals, Inc. |
Toll-like receptor agonist formulations and their use
|
|
UY32072A
(es)
|
2008-08-26 |
2010-03-26 |
Boehringer Ingelheim Int |
Tienopirimidinas para composiciones farmacéuticas
|
|
US20100068302A1
(en)
|
2008-09-17 |
2010-03-18 |
Traslational Cancer Drugs Pharma, S.L. |
Methods and compositions for the treatment of cancer
|
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
|
US20100111901A1
(en)
|
2008-11-03 |
2010-05-06 |
Auspex Pharmaceuticals, Inc. |
Triazole inhibitors of aromatase
|
|
JP5752601B2
(ja)
|
2008-12-08 |
2015-07-22 |
ブイエム ファーマ エルエルシー |
タンパク質受容体チロシンキナーゼ阻害薬の組成物
|
|
WO2010068920A2
(en)
|
2008-12-12 |
2010-06-17 |
Auspex Pharmaceutical, Inc. |
Diaminoquinazoline inhibitors of dihydrofolate reductase
|
|
PA8851101A1
(es)
|
2008-12-16 |
2010-07-27 |
Lilly Co Eli |
Compuesto amino pirazol
|
|
WO2010080570A2
(en)
|
2008-12-18 |
2010-07-15 |
New York University |
Tumor therapy with antitumor agents in combination with sindbis virus-based vectors
|
|
US20100173013A1
(en)
|
2009-01-08 |
2010-07-08 |
Denis Drygin |
Treatment of neoplastic disorders using combination therapies
|
|
CN102307475A
(zh)
*
|
2009-02-04 |
2012-01-04 |
彼帕科学公司 |
用与生长因子抑制剂组合的parp抑制剂治疗肺癌
|
|
EP2393488B1
(en)
|
2009-02-06 |
2019-06-19 |
University Of Southern California |
Therapeutic compositions comprising monoterpenes
|
|
WO2010104945A1
(en)
|
2009-03-11 |
2010-09-16 |
Plexxikon, Inc. |
Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
|
|
CA2756072A1
(en)
|
2009-03-30 |
2010-10-14 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
|
WO2010114805A1
(en)
|
2009-03-31 |
2010-10-07 |
The Trustees Of The University Of Pennsylvania |
Methods of treating cancer with phenformin
|
|
WO2010114881A1
(en)
|
2009-04-01 |
2010-10-07 |
Progenra Inc. |
Anti-neoplastic compounds, compositions and methods
|
|
CA2758071C
(en)
|
2009-04-06 |
2018-01-09 |
Agios Pharmaceuticals, Inc. |
Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use
|
|
US20100291025A1
(en)
|
2009-04-13 |
2010-11-18 |
Auspex Pharmaceuticals, Inc. |
Indazole inhibitors of tyrosine kinase
|
|
US20110053968A1
(en)
|
2009-06-09 |
2011-03-03 |
Auspex Pharmaceuticals, Inc. |
Aminopyrimidine inhibitors of tyrosine kinase
|
|
WO2010144808A2
(en)
|
2009-06-12 |
2010-12-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Identification of dsg-3 as a biomarker for the detection of metastasis in lymph nodes
|
|
US8232318B2
(en)
|
2009-07-31 |
2012-07-31 |
The General Hospital Corporation |
Approaches to treat cancer using HB-EGF inhibitors
|
|
HRP20130951T1
(hr)
|
2009-08-28 |
2013-11-22 |
Takeda Pharmaceutical Company Limited |
Spojevi heksahidrooksazinopteridina za uporabu kao inhibitori mtor
|
|
SG179083A1
(en)
|
2009-09-11 |
2012-04-27 |
Cylene Pharmaceuticals Inc |
Pharmaceutically useful heterocycle-substituted lactams
|
|
US20110071136A1
(en)
|
2009-09-16 |
2011-03-24 |
Cylene Pharmaceuticals, Inc |
Novel tricyclic protein kinase modulators
|
|
MY160064A
(en)
|
2009-09-28 |
2017-02-15 |
Hoffmann La Roche |
Benzoxazepin pi3k inhibitor compounds and methods of use
|
|
US8304577B2
(en)
|
2009-10-09 |
2012-11-06 |
Bristol-Myers Squibb Company |
Modulators of G protein-coupled receptor 88
|
|
PE20121172A1
(es)
*
|
2009-10-14 |
2012-09-05 |
Merck Sharp & Dohme |
Piperidinas sustituidas con actividad en la hdm2
|
|
SG10201407757XA
(en)
|
2009-10-23 |
2015-01-29 |
Millennium Pharm Inc |
Anti-gcc antibody molecules and related compositions and methods
|
|
JP5802676B2
(ja)
|
2009-12-04 |
2015-10-28 |
センワ バイオサイエンシズ インコーポレイテッド |
Ｃｋ２阻害剤としてのピラゾロピリミジンおよび関連複素環化合物
|
|
US8445517B2
(en)
|
2009-12-11 |
2013-05-21 |
Dana-Farber Cancer Institute |
Stat modulators
|
|
US20110195066A1
(en)
|
2010-02-05 |
2011-08-11 |
Auspex Pharmaceuticals, Inc. |
Quinoline inhibitors of tyrosine kinase
|
|
EP2539347A2
(en)
|
2010-02-24 |
2013-01-02 |
Auspex Pharmaceuticals, Inc. |
Trimethoxyphenyl inhibitors of tyrosine kinase
|
|
UY33241A
(es)
|
2010-02-26 |
2011-09-30 |
Boehringer Ingelheim Int |
?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
|
|
MX2012009851A
(es)
|
2010-02-26 |
2012-09-12 |
Boehringer Ingelheim Int |
Tienopirimidinas que contienen un grupo alquilo sustituido para composiciones farmaceuticas.
|
|
EP2542089B1
(en)
|
2010-03-05 |
2017-01-18 |
Karyopharm Therapeutics, Inc. |
Nuclear transport modulators and uses thereof
|
|
US8389525B2
(en)
|
2010-05-05 |
2013-03-05 |
Renee Desai |
Small molecules for inhibition of protein kinases
|
|
CA2798760A1
(en)
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
2-aminopyridine derivatives useful as inhibitors of atr kinase
|
|
JP2013529203A
(ja)
*
|
2010-05-14 |
2013-07-18 |
ジェネンテック， インコーポレイテッド |
治療方法
|
|
CN103608010A
(zh)
*
|
2010-08-02 |
2014-02-26 |
中央佛罗里达大学研究基金公司 |
作为stat蛋白的抑制剂的取代的2-羟基-4-(2-(苯基磺酰氨基)乙酰氨基)苯甲酸类似物
|
|
AU2011292044A1
(en)
*
|
2010-08-18 |
2013-04-04 |
Del Mar Pharmaceuticals |
Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
|
|
US9029103B2
(en)
*
|
2010-08-27 |
2015-05-12 |
Illumina Cambridge Limited |
Methods for sequencing polynucleotides
|
|
US20120213854A1
(en)
|
2010-09-30 |
2012-08-23 |
Fetzer Oliver S |
Methods of treating a subject and related particles, polymers and compositions
|
|
JP2013545749A
(ja)
|
2010-11-10 |
2013-12-26 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
複素環化合物及びその使用
|
|
SG182016A1
(en)
*
|
2010-12-14 |
2012-07-30 |
Univ Singapore |
Method of detecting resistance to cancer therapy
|
|
CA2868302A1
(en)
*
|
2012-03-23 |
2013-09-26 |
Dennis M. Brown |
Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
|
|
WO2013169600A1
(en)
*
|
2012-05-09 |
2013-11-14 |
Delmar Pharmaceuticals |
Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies
|
|
US8729286B2
(en)
*
|
2012-05-10 |
2014-05-20 |
Massachusetts Institute Of Technology |
Platinum compounds as treatment for cancers, and related methods, kits, and compositions
|